← Open Payments lookup

SAMIR GUPTA: Open Payments

NPI 1861457178 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$804 in 31 payments from 10 companies in 2025. Trend: 2023 $297 · 2024 $204 · 2025 $804

Food & beverage: $692Education: $111
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$198
Otsuka America Pharmaceutical, Inc.5$121
Teva Pharmaceuticals USA, Inc.1$111
Lundbeck LLC4$74
Janssen Pharmaceuticals, Inc3$66
E.R. Squibb & Sons, L.L.C.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$58
Supernus Pharmaceuticals, Inc.2$49
Alkermes, Inc.2$32
Corium, LLC2$27

Products named: FANAPT, ABILIFY ASIMTUFII, ABILIFY MAINTENA, INVEGA SUSTENNA, COBENFY, CAPLYTA, Qelbree, ARISTADA.

Industry payments across IN — which companies pay providers there.